The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,773.50
Bid: 1,772.00
Ask: 1,772.50
Change: 12.50 (0.71%)
Spread: 0.50 (0.028%)
Open: 1,770.00
High: 1,776.00
Low: 1,766.00
Prev. Close: 1,761.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London open: UK stocks rise ahead of data-heavy week, M&S falls

Mon, 05th Jan 2015 08:18

After an initial dip, UK stocks pushed into positive territory early on Monday as traders returned to their desks after the festive holidays in an optimistic mood.London's FTSE 100 index was up 0.4% at 6,571, quickly bouncing off an intraday low of 6,522.59 reached shortly after the open."This Monday finally sees the return of most traders from the Christmas break and also the return of the volume into these markets," said analyst James Hughes from Alpari UK.This week looks set to be fairly busy in terms of economic data, with inflation figures and purchasing managers' indices (PMIs) from the Eurozone, a Bank of England rate decision and the US jobs report all due for release."So anyone who thought they could just ease themselves back into things with a comfortable week will have a bit of a shock coming," Hughes said.The positive start for UK markets followed an upbeat session in China overnight as the Shanghai Composite Index rose 3.6% to a new five and a half-year high amid speculation that policymakers will ease monetary policy further.Figures released last week showed that factory output growth in China slowed down in December with the government's 'official' manufacturing PMI falling from 50.3 to an 18-month low of 50.1. HSBC's own manufacturing PMI showed a contraction in the sector last month with a reading under the break-even point of 50.M&S hit by downgradeDepartment store chain Marks & Spencer was trading in the red on Monday after analysts at Societe Generale downgraded their recommendation for the stock from 'buy' to 'hold'.Mike van Dulken, head of research at Accendo Markets, said that M&S is expected to join others in the retail industry this week by revealing a "slump" in Christmas sales. "While M&S tends to do well with its festive food offering, falling food prices and changing habits with cost conscious consumers shopping elsewhere may have kept a lid on sales for the division," he added.GlaxoSmithKline was lower after JPMorgan Cazenove lowered the stock to 'underweight', while pharmaceutical peer AstraZeneca was upgraded by the US bank to 'neutral'.Precious metals producers Fresnillo and Randgold Resources were high risers early on as gold and silver prices rose.AIM-listed Stevia ingredients maker PureCircle moved higher after saying that launches of lower-calorie fizzy drinks by Coca-Cola and PepsiCo resulted in a 24% jump in sales in the first half.techMARK 2,972.20 +0.46%FTSE 100 6,571.45 +0.36%FTSE 250 16,137.43 +0.53%FTSE 100 - RisersFresnillo (FRES) 789.00p +3.14%Carnival (CCL) 3,013.00p +2.83%International Consolidated Airlines Group SA (CDI) (IAG) 498.90p +2.44%easyJet (EZJ) 1,723.00p +2.38%Barratt Developments (BDEV) 471.00p +2.28%Ashtead Group (AHT) 1,190.00p +2.15%Aberdeen Asset Management (ADN) 441.70p +1.92%Taylor Wimpey (TW.) 137.40p +1.85%Randgold Resources Ltd. (RRS) 4,494.00p +1.84%Reckitt Benckiser Group (RB.) 5,260.00p +1.84%FTSE 100 - FallersMarks & Spencer Group (MKS) 470.50p -1.38%BP (BP.) 405.50p -1.21%Weir Group (WEIR) 1,866.00p -0.90%Morrison (Wm) Supermarkets (MRW) 181.60p -0.87%Aggreko (AGK) 1,486.00p -0.73%GlaxoSmithKline (GSK) 1,374.50p -0.61%Royal Dutch Shell 'A' (RDSA) 2,155.00p -0.60%BG Group (BG.) 859.70p -0.52%Royal Dutch Shell 'B' (RDSB) 2,225.00p -0.47%Tullow Oil (TLW) 412.20p -0.46%FTSE 250 - RisersHikma Pharmaceuticals (HIK) 2,086.00p +5.25%Poundland Group (PLND) 335.00p +4.10%Indivior (INDV) 153.10p +2.75%Ocado Group (OCDO) 426.50p +2.55%RPC Group (RPC) 514.50p +2.29%Ophir Energy (OPHR) 147.80p +2.28%Supergroup (SGP) 869.50p +2.11%Ted Baker (TED) 2,246.00p +2.09%Kier Group (KIE) 1,520.00p +2.01%Berkeley Group Holdings (The) (BKG) 2,514.00p +1.99%FTSE 250 - FallersBrit (BRIT) 264.90p -2.43%Nostrum Oil & Gas (NOG) 430.70p -2.11%Zoopla Property Group (WI) (ZPLA) 195.00p -1.71%JPMorgan Emerging Markets Inv Trust (JMG) 585.00p -1.52%Spire Healthcare Group (SPI) 368.00p -1.47%Barr (A.G.) (BAG) 580.00p -1.44%Synthomer (SYNT) 234.00p -1.43%Premier Oil (PMO) 162.70p -1.21%Rank Group (RNK) 158.10p -1.19%Allied Minds (ALM) 364.00p -1.09%
More News
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.